Immune Thrombocytopenia (ITP) Market Growing Steadily at 6.7% CAGR by 2027
Rising awareness towards rare diseases, Rising R&D leading to the introduction of new drugs, cost-efficient therapeutic approach, government initiatives for Immune thrombocytopenia field is driving the market during the forecast period.
View full press release